Our data indicated that KPT-330 inhibited cell proliferation and induced cell-cycle arrest and apoptosis of CML cell lines and primary blasts, not only in the IM-sensitive, but also IM-resistant CML with BCR-ABL T315I mutation. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.